| | | | | |
PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated | $9,1700 | +0,22% | $118,87M | $16,49K | |
PLYX Polaryx Therapeutics, Inc. Common Stock | $2,2100 | +0,91% | $118,83M | $49,48K | |
PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares | $10,7350 | +0,52% | $118,41M | $2,93K | |
DMO Western Asset Mortgage Opportunity Fund Inc. | $10,4100 | +0,19% | $118,27M | $27,00K | |
ENGN enGene Therapeutics Inc. Common Stock | $1,7800 | +0,57% | $117,90M | $640,75K | |
ANIX Anixa Biosciences, Inc. | $3,4300 | +0,59% | $117,71M | $192,22K | |
OPRX OptimizeRx Corporation Common Stock | $6,8500 | +4,58% | $117,65M | $176,88K | |
| $1,0400 | +1,96% | $117,55M | $818,49K | |
JELD JELD-WEN Holding, Inc. | $1,7514 | +21,60% | $117,16M | $6,57M | |
MCN XAI Madison Equity Premium Income Fund | $5,6000 | -0,71% | $117,14M | $71,62K | |
WSBK Winchester Bancorp, Inc. Common Stock | $13,0100 | -0,23% | $117,11M | $3,74K | |
NEOV NeoVolta Inc. Common Stock | $2,5200 | +2,02% | $116,95M | $1,12M | |
BRKH Burtech Acquisition Corp II Class A Ordinary Shares | $9,9500 | +0,10% | $116,90M | $12,22K | |
| $8,2100 | +1,23% | $116,86M | $33,60K | |
MBOT Microbot Medical, Inc. Common Stock | $1,8300 | +3,39% | $116,86M | $641,12K | |
